News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First Time Unlucky for Australian Listing of Pharmaxis Ltd (PXS.AX)'s Cystic Fibrosis Drug



4/27/2011 7:52:20 AM

SCRIP -- Pharmaxis' first attempt at getting its cystic fibrosis therapy Bronchitol (mannitol) included in Australia's reimbursement scheme has been unsuccessful, although the company remains confident it will be eventually be covered. The inhaled dry powder product was considered at the March meeting.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES